Landscape of Cell Heterogeneity and Evolutionary Trajectory in Ulcerative Colitis-associated Colon Cancer Revealed by Single-cell Rna Sequencing

Quan Wang,Zhu Wang,Zhen Zhang,Wei Zhang,Mengmeng Zhang,Zhanlong Shen,Yingjiang Ye,Kewei Jiang,Shan Wang
DOI: https://doi.org/10.21203/rs.3.rs-60886/v1
2020-01-01
Abstract:Abstract Background: Patients with colitis-associated cancer (CAC), a particular kind of colorectal cancer that develops from inflammatory bowel diseases (IBDs), have an earlier morbidity and a poorer prognosis. However, in CAC, single cell transcriptome analysis of the microenvironment composition and characteristics has yet to be performed. To understand the intra-tumor heterogeneity in CAC and to reveal a potential evolutionary trajectory from ulcerative colitis (UC) to CAC at the single cell level. Methods: Fresh samples of tumor- and adjacent tissue, from a CAC patient with pT3N1M0, were examined by single cell RNA sequencing (scRNA-seq). Data from The Cancer Genome Atlas (TCGA) and The Human Protein Atlas were used to confirm the different expression levels in normal and tumor tissues and to determine their relationships with prognosis. Results: Ultimately, 4,777 single-cell transcriptomes (1220 genes per cell) were studied, which composed of 2,250 (47%) and 2,527(53%) originated from tumor- and non-malignant tissue, respectively. And we defined the composition of cancer-associated stromal cells and identified six cell clusters included myeloid, T and B cells, fibroblasts, endothelial and epithelial cells. Likewise, the notable pathways and transcription factors (TFs) involved of these cell clusters were analyzed and described. Moreover, we graphed the precise cellular composition and developmental trajectory from UC to UC-associated colon cancer, and predicted that CD74, CLCA1 and DPEP1 had a potential role in the disease progression. Conclusions: scRNA-seq technology could reveal intratumor cell heterogeneity in ulcerative colitis-associated colon cancer, and might provide a promising direction to seek the novel potential therapeutic targets in the evolution from IBD to CAC.
What problem does this paper attempt to address?